...
首页> 外文期刊>The journal of immunology >Vaccination with Plasmid DNA Activates Dendritic Cells via Toll-Like Receptor 9 (TLR9) but Functions in TLR9-Deficient Mice
【24h】

Vaccination with Plasmid DNA Activates Dendritic Cells via Toll-Like Receptor 9 (TLR9) but Functions in TLR9-Deficient Mice

机译:质粒DNA疫苗接种通过Toll样受体9(TLR9)激活树突状细胞,但在TLR9缺陷型小鼠中起作用。

获取原文
           

摘要

We analyzed whether the immunobiology of vaccinating plasmid DNA containing a transcription unit for OVA is influenced by immunostimulatory CpG motifs in the plasmid backbone. Indeed, plasmid DNA differentially activated in vitro myeloid and plasmacytoid dendritic cells (DCs) provided they expressed the CpG-DNA receptor, Toll-like receptor 9 (TLR9). Dependent on the DC subset, activation resulted in type 1 IFN production, while both DC subsets produced IL-6 and up-regulated expression of costimulatory molecules CD40 and CD86. In vivo, however, even upon repeated vaccination with plasmid DNA, priming of OVA-specific CTL and clonal expansion of SIINFEKL-specific CD8 T cells were equal in TLR9-positive and TLR9- or MyD88-negative mice. Overall, these results negate a dominant role of CpG-DNA/TLR9 interactions in long-term vaccination protocols.
机译:我们分析了包含OVA转录单位的接种质粒DNA的免疫生物学是否受到质粒主链中免疫刺激性CpG基序的影响。实际上,质粒DNA在体外表达髓样细胞和浆细胞样树突状细胞(DC)时具有差异性激活作用,前提是它们表达了CpG-DNA受体Toll样受体9(TLR9)。依赖于DC子集,激活导致1型IFN产生,而两个DC子集均产生IL-6和共刺激分子CD40和CD86的表达上调。然而,在体内,即使在重复接种质粒DNA后,在TLR9阳性和TLR9或MyD88阴性的小鼠中,OVA特异性CTL的引发和SIINFEKL特异性CD8 T细胞的克隆扩增也相同。总体而言,这些结果否定了CpG-DNA / TLR9相互作用在长期疫苗接种方案中的主导作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号